Department of Health and Social Care
£20m announced to fund vaccines for coronavirus and other infectious diseases
Government has pledged £20 million to develop a new vaccine for coronavirus and other infectious diseases
The Government yesterday pledged £20 million to develop new vaccines to combat the world’s deadliest diseases, amid concerns over the ongoing novel coronavirus outbreak in China.
When visiting the Public Health England’s Porton Down laboratory last week, Health Secretary Matt Hancock announced the UK will ramp up efforts to fund ground-breaking research into vaccines, diagnostics and cures to fight against the threat of future viruses.
The new funding will support work developing new vaccines for epidemics, including their three new programmes to develop vaccines against the novel coronavirus, 2019-nCoV. These projects aim to advance 2019-nCoV vaccine candidates into clinical testing as quickly as possible.
Health Secretary Matt Hancock yesterday said:
Vaccines are our best defense against a host of deadly diseases, including coronavirus. The UK is a hub of world-leading and pioneering research, and it is vital that we lead the way in developing new vaccines to target global threats with scientists from across the world.
The £20 million announced today will help our globally recognised vaccine development capabilities continue to develop new defences against emerging diseases including coronavirus. It’s paramount we invest in vital research about infectious diseases, keeping the UK at the forefront of modern-day science so we can share this knowledge globally.
The £20m in new funding will go to the Coalition for Epidemic Preparedness Innovations (CEPI) – an innovative global partnership between public, private, philanthropic, and civil society organisations launched in Davos in 2017 to develop vaccines to stop future epidemics.
CEPI was originally formed in response to the Ebola epidemic in West Africa.
Dr Richard Hatchett, CEO of CEPI, yesterday said:
CEPI welcomes the UK’s continued support and funding for our vital work, which comes at a crucial moment as the world races to respond to the emergence of a novel coronavirus. The rapid global spread and unique epidemiological characteristics of the virus are deeply concerning.
Our hope is that, with our partners, we can get an investigational vaccine from gene sequencing of the pathogen through to clinical testing in 16 weeks. The earliest stage of clinical trials (Phase I), to establish the safety of investigational vaccines, would take around two to four months.
This is an extremely ambitious timeline – indeed, it would be unprecedented in the of field vaccine development. It is important to remember that even if we are successful - and there can be no guarantee - there will be further challenges to navigate before we can make vaccines more broadly available.
The Government is also in initial stages of talks between NIHR and UKRI regarding plans to run a rapid research call to support the global response to 2019-nCoV.
Latest News from
Department of Health and Social Care
Taking multiple medicines? Support the Yellow Card scheme by reporting suspected side effects18/02/2020 10:10:10
The Medicines and Healthcare products Regulatory Agency (MHRA) launches a week long social media campaign to raise awareness about the importance of reporting suspected side effects using the Yellow Card Scheme.
Mumps outbreaks across England14/02/2020 13:05:00
Public Health England and NHS England urge people to ensure they have 2 doses of measles, mumps, and rubella (MMR) vaccine as mumps cases rise to highest levels in a decade.
New bill gives hospitals power to develop personalised treatment13/02/2020 14:10:00
The Medicines and Medical Devices Bill introduces new safety measures, increases the professions that can prescribe low-risk medicines and allows hospitals to develop personalised medicines.
Coronavirus: Health Secretary's statement to Parliament12/02/2020 15:10:00
The Secretary of State for Health and Social Care Matt Hancock updated Parliament on the government's response to coronavirus (11 February 2020).
Storage limit for frozen eggs, sperm and embryos to be reconsidered12/02/2020 13:10:00
The government is seeking views on reviewing the current 10-year storage limit for eggs, sperm and embryos, to give more people the opportunity to start a family.
Government to monitor impact of coronavirus on UK medicine supply12/02/2020 11:33:00
The Department of Health and Social Care is evaluating the potential impact of coronavirus on the supply of medicines and medical goods.
My Right to Healthcare12/02/2020 10:10:10
Groundswell and the LHHP have produced ‘My Right to Healthcare’ cards which explain to GP surgeries the rights of homeless people to register for primary care.
Government considers more flexible training for healthcare professionals switching discipline11/02/2020 14:51:00
People who are already working as healthcare professionals could train to become doctors and nurses more quickly now that the UK has left the EU.